Evidence map›Paper›PMID 40751884›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2025

Improvement in sleep following treatment initiation in newly diagnosed, treatment-naïve patients with Wilson's disease.

Wojciech Jernajczyk, Tomasz Litwin, Agnieszka Antos, Jan P Bembenek

Abstract read
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Wojciech Jernajczyk *Department of Clinical Neurophysiology, Institute of Psychiatry and Neurology, Sobieskiego 9, Warsaw, 02-957, Poland.
Tomasz LitwinDepartment of Neurology, Stroke Unit and Rehabilitation Subunit, Wolski Hospital, Warsaw, Poland.
Agnieszka AntosSecond Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland.
Jan P Bembenek *Department of Clinical Neurophysiology, Institute of Psychiatry and Neurology, Sobieskiego 9, Warsaw, 02-957, Poland. jbembenek@o2.pl.ORCID http://orcid.org/0000-0001-9424-1873

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSleep disturbances (SD) are common in chronic liver diseases and neurodegenerative disorders, including Wilson's disease (WD). However, there is limited evidence regarding improvement in sleep quality following initiation of anti-copper therapy in treatment-naïve WD patients.

methodsWe performed and evaluated video-polysomnography (vPSG) in six newly diagnosed, treatment-naïve WD patients. All patients underwent overnight vPSG before and after initiation of anti-copper treatment.

resultsNone of the patients reported subjective SD during routine clinical assessment. Objective improvement in sleep efficiency (SE) was observed in five patients, with increases of 6.4%, 7.4%, 17.1%re, 17.3%, and 45.6%, respectively. In three patients, SE normalized (> 90%) after treatment. One patient demonstrated a decline in SE on follow-up (73.5% vs. 67.4%).

conclusionsInitiation of anti-copper treatment in newly diagnosed WD patients may lead to improvements in sleep quality, in addition to neurological symptom relief. These preliminary findings warrant confirmation in larger, controlled studies.

Indexed as

Hepatolenticular DegenerationSleep Wake DisordersAdolescentAdultFemaleHumansMalePolysomnographyTreatment OutcomeYoung AdultAnti-copper treatmentCopperPolysomnographySleep effectivenessWilson’s disease

Identifiers

PMID40751884
PMCPMC12488830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.